Last updated on December 2018

A Phase 2 Multicenter Study Evaluating Subjects With Relapsed/Refractory Mantle Cell Lymphoma


Brief description of study

Study KTE-C19-102 is a phase 2, multicenter, open-label study evaluating the efficacy of KTE-X19 in subjects with Relapsed/Refractory MCL

Clinical Study Identifier: NCT02601313

Contact Investigators or Research Sites near you

Start Over

Javier Munoz, MD, FACP

Banner MD Anderson
Gilbert, AZ United States
  Connect »

Hormoz Mirshkarlo

City of Hope
Duarte, CA United States
  Connect »

Medical Information

UC San Diego Moores Cancer Center
La Jolla, CA United States
  Connect »

David Miklos, MD, PhD

Stanford University
Stanford, CA United States
  Connect »

Juli Murphy

Sarah Cannon
Denver, CO United States
  Connect »

Amer Beitinjaneh

University of Miami
Miami, FL United States
  Connect »

Matthew Scott

H Lee Moffitt Cancer Center
Tampa, FL United States
  Connect »

Neera Jagirdar

Winship Cancer Institute of Emory University
Atlanta, GA United States
  Connect »

Ray Robinson

University of Chicago
Chicago, IL United States
  Connect »

Michael Rocchio

Dana-Farber Cancer Institute
Boston, MA United States
  Connect »

Marie Ventimiglia

Barbara Ann Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Kelly Azzollini

Hackensack University Medical Center
Hackensack, NJ United States
  Connect »

Frances Batarse

University of Rochester Medical Center
Rochester, NY United States
  Connect »

Donna Abounader

Cleveland Clinic Foundation
Cleveland, OH United States
  Connect »

Laurie Delanty

Robert W. Franz Cancer Research Center
Portland, OR United States
  Connect »

Christy Riggins

Sarah Cannon Research Institute
Nashville, TN United States
  Connect »

Sandy Li

Baylor Charles A. Sammons Cancer Center
Dallas, TX United States
  Connect »

Michael (Luhua) Wang, MD

University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

JoDell McCracken

Methodist Hospital
San Antonio, TX United States
  Connect »

Melinh Jones-Nozynski

Swedish Cancer Institute
Seattle, WA United States
  Connect »

John Timmerman, MD

University California Los Angeles (UCLA)
Los Angeles, CA United States
  Connect »

Bonnie Toaso

Duke University Medical Center
Durham, NC United States
  Connect »

Henry Fung, MD

Fox Chase Cancer Center
Philadelphia, PA United States
  Connect »

Olalekan Oluwole, MD

Vanderbilt University Medical Center
Nashville, TN United States
  Connect »

Samantha M. Jaglowski, MD, MPH

James Cancer Hospital and Solove Research Institute
Columbus, OH United States
  Connect »

Catherine Thieblemont, MD

Hospital Saint Louis
Paris, France
  Connect »

Patrick Stiff, MD

Loyola University Chicago
Maywood, IL United States
  Connect »

Tom van Meerten, MD

University Medical Center Groningen
Groningen, Netherlands
  Connect »

Pieternella Lugtenburg, MD

Erasmus Medical Center
Rotterdam, Netherlands
  Connect »

Maria Jose Kersten, MD

Academisch Medisch Centrum
Amsterdam, Netherlands
  Connect »

Noel Miliped, Prof. MD

Centre Hospitalier Universitaire (CHU)
Bordeaux, France
  Connect »

Medical Information

Hopital Haut-Leveque
Nantes, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.